| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $28,0100 | -4,73 % | $1,74B | $853,63K | |
SGRY Surgery Partners, Inc. Common Stock | $13,2000 | -1,20 % | $1,74B | $2,12M | |
GAB The Gabelli Equity Trust Inc. | $5,6100 | +0,00 % | $1,74B | $1,45M | |
HURN Huron Consulting Group Inc. | $110,42 | +2,82 % | $1,74B | $351,53K | |
ENVX Enovix Corporation Common Stock | $8,5900 | +7,64 % | $1,74B | $13,24M | |
PAYO Payoneer Global Inc. Common Stock | $5,4250 | +4,33 % | $1,74B | $5,92M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14,9200 | +0,13 % | $1,73B | $165,17K | |
STGW Stagwell Inc. Class A Common Stock | $7,3800 | +5,28 % | $1,73B | $2,69M | |
CASH Pathward Financial, Inc. Common Stock | $80,9700 | -1,54 % | $1,73B | $141,62K | |
SNDX Syndax Pharmaceuticals, Inc. | $18,8350 | -3,85 % | $1,73B | $1,49M | |
STRA Strategic Education, Inc. Common Stock | $79,3250 | +3,36 % | $1,73B | $254,03K | |
CAPR Capricor Therapeutics Inc | $28,5350 | -4,77 % | $1,73B | $726,60K | |
AAPG Ascentage Pharma Group International American Depository Shares | $19,0500 | -4,80 % | $1,73B | $8,26K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $9,0600 | -2,69 % | $1,73B | $7,29M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $24,6400 | -1,44 % | $1,73B | $202,78K | |
